Synlogic, Inc.
General ticker "SYBX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.0M (TTM average)
Synlogic, Inc. follows the US Stock Market performance with the rate: 3.9%.
Estimated limits based on current volatility of 2.4%: low 0.61$, high 0.64$
Factors to consider:
- Total employees count: 1 as of 2024
- Top business risk factors: Dependency on SYNB1934, Strategic risks and growth management, Potential dissolution or bankruptcy, Insufficient funding, History of losses
- Current price 18.7% below estimated low
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.90$, 3.06$]
- 2025-12-31 to 2026-12-31 estimated range: [0.78$, 2.68$]
Financial Metrics affecting the SYBX estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -186.07 <= 0.07
- Positive: Investing cash flow per share per price, % of 148.93 > -0.65
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 64.31 > 64.25
Short-term SYBX quotes
Long-term SYBX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.37MM | $0.01MM | $0.00MM |
| Operating Expenses | $58.53MM | $40.96MM | $4.01MM |
| Operating Income | $-55.16MM | $-40.95MM | $-4.01MM |
| Non-Operating Income | $-6.10MM | $17.60MM | $3.00MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $43.97MM | $9.15MM | $0.04MM |
| Income(Loss) | $-61.26MM | $-23.35MM | $-1.00MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Profit(Loss)* | $-57.28MM | $-23.36MM | $-1.00MM |
| Stockholders Equity | $42.66MM | $12.75MM | $11.86MM |
| Assets | $75.55MM | $19.83MM | $15.45MM |
| Operating Cash Flow | $-51.61MM | $-31.66MM | $-4.36MM |
| Capital expenditure | $0.21MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $38.77MM | $25.34MM | $0.17MM |
| Financing Cash Flow | $20.94MM | $0.17MM | $0.00MM |
| Earnings Per Share** | $-8.81 | $-1.92 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.